ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children
The goal of the study is to evaluate the application of Besivance™ (besifloxacin ophthalmic suspension, 0.6%) to treat congenital nasolacrimal duct obstruction in children. The hypothesis of the study is that Besivance™ is as safe and effective as the current standard of care for the treatment of nasolacrimal duct obstruction in children.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants#847203
- Improving Sleep Quality in Flap Patients in the SICU#1088850
- Rapid Assessment of Avoidable Blindness Report: Malaysia, Kelantan, Terengganu and Pahang (2014)#411961
- Rapid Assessment of Avoidable Blindness Report: Malaysia, Kuala Lumpur, Putrajaya, Selangor and Negeri Sembilan, (2014)#411962
- Rapid Assessment of Avoidable Blindness Report: Philippines, Western Visayas, Negros (2005)#436459
Record · ID 808036
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive